Cooper Companies Trades at 18.1x Forward P/E Versus West Pharma’s 31.7x
Cooper Companies has a forward P/E of 18.13, PEG of 2.33 and P/B of 1.97, earning a Value grade of B compared to West Pharmaceutical’s forward P/E of 31.74, PEG of 3.32 and P/B of 5.52, which garnered a D grade. Both stocks hold Zacks Rank #2.
1. Valuation Metrics Comparison
Cooper Companies currently trades at a forward P/E ratio of 18.13 and a P/B ratio of 1.97, compared to West Pharmaceutical’s forward P/E of 31.74 and P/B of 5.52. Cooper’s PEG ratio stands at 2.33 while West’s is 3.32, indicating lower valuation multiples for Cooper.
2. Value Grades and Ranks
Both companies hold a Zacks Rank of #2 (Buy), reflecting positive earnings estimate revisions. In the Style Scores system, Cooper Companies earned a Value grade of B, whereas West Pharmaceutical received a D, underscoring Cooper’s stronger value profile.
3. Investment Implications
Investors seeking undervalued names in the medical-dental supplies sector may favor Cooper Companies given its more attractive valuation metrics and higher Value grade. The lower multiples and superior grade suggest potential upside relative to West Pharmaceutical, assuming earnings growth aligns with estimates.